Griffith Harsh

Publications

• A perspective on craniopharyngioma. Lober RM, Harsh GR. World Neurosurg. 2013 May-Jun; 79 (5-6): 645-6
• Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Atalar B, Choi CY, Harsh GR, Chang SD, Gibbs IC, Adler JR, Soltys SG. Neurosurgery. 2013; 72 (2): 180-5; discussion 185
• Diffusion-Weighted MRI: Distinction of Skull Base Chordoma from Chondrosarcoma. Yeom KW, Lober RM, Mobley BC, Harsh G, Vogel H, Allagio R, Pearson M, Edwards MS, Fischbein NJ. AJNR Am J Neuroradiol. 2013; 34 (5): 1056-61
• Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage. Yamaguchi Y, Shao Z, Sharif S, Du XY, Myles T, Merchant M, Harsh G, Glantz M, Recht L, Morser J, Leung LL. J Biol Chem. 2013; 288 (5): 3097-111
• Mucocele formation under pedicled nasoseptal flap. Vaezeafshar R, Hwang PH, Harsh G, Turner JH. Am J Otolaryngol. 2012 Sep-Oct; 33 (5): 634-6
• Cochlea Radiation Dose Correlates with Hearing Loss After Stereotactic Radiosurgery of Vestibular Schwannoma. Hayden Gephart MG, Hansasuta A, Balise RR, Choi C, Sakamoto GT, Venteicher AS, Soltys SG, Gibbs IC, Harsh GR, Adler JR, Chang SD. World Neurosurg. 2012
• Management of intracranial and extracranial chordomas with CyberKnife stereotactic radiosurgery. Jiang B, Veeravagu A, Lee M, Harsh GR, Lieberson RE, Bhatti I, Soltys SG, Gibbs IC, Adler JR, Chang SD. J Clin Neurosci. 2012; 19 (8): 1101-6
• Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control. Choi CY, Chang SD, Gibbs IC, Adler JR, Harsh GR, Lieberson RE, Soltys SG. Int J Radiat Oncol Biol Phys. 2012; 84 (2): 336-42
• The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL. Proc Natl Acad Sci U S A. 2012; 109 (17): 6662-7
• What is the optimal treatment of large brain metastases? An argument for a multidisciplinary approach. Choi CY, Chang SD, Gibbs IC, Adler JR, Harsh GR, Atalar B, Lieberson RE, Soltys SG. Int J Radiat Oncol Biol Phys. 2012; 84 (3): 688-93
• Bevacizumab improves quality of life in patients with recurrent glioblastoma. Nagpal S, Harsh G, Recht L. Chemother Res Pract. 2011: 2011 602812
• Extravascular Papillary Endothelial Hyperplasia Mimicking Neoplasm Following Radiosurgery. Karamchandani J, Vogel H, Fischbein N, Gibbs I, Edwards MS, Harsh G. Neurosurgery. 2011
• Gene-protein correlation in single cells. Renfrow JJ, Scheck AC, Dhawan NS, Lukac PJ, Vogel H, Chandler JP, Raizer JJ, Harsh GR, Chakravarti A, Bredel M. Neuro Oncol. 2011; 13 (8): 880-5
• Multisession stereotactic radiosurgery for vestibular schwannomas: single-institution experience with 383 cases. Hansasuta A, Choi CY, Gibbs IC, Soltys SG, Tse VC, Lieberson RE, Hayden MG, Sakamoto GT, Harsh GR, Adler JR, Chang SD. Neurosurgery. 2011; 69 (6): 1200-9
• NFKBIA deletion in glioblastomas. Bredel M, Scholtens DM, Yadav AK, Alvarez AA, Renfrow JJ, Chandler JP, Yu IL, Carro MS, Dai F, Tagge MJ, Ferrarese R, Bredel C, Phillips HS, Lukac PJ, Robe PA, Weyerbrock A, Vogel H, Dubner S, Mobley B, He X, Scheck AC, Sikic BI, Aldape KD, Chakravarti A, Harsh GR. N Engl J Med. 2011; 364 (7): 627-37
• Stereotactic radiosurgery of cranial nonvestibular schwannomas: results of single- and multisession radiosurgery. Choi CY, Soltys SG, Gibbs IC, Harsh GR, Sakamoto GT, Patel DA, Lieberson RE, Chang SD, Adler JR. Neurosurgery. 2011; 68 (5): 1200-8; discussion 1208
• Retrosellar intracranial extracerebral glioneuronal heterotopion: case report. Karamchandani J, Fischbein N, Harsh G, Katznelson L, Vogel H. Clin Neuropathol. 2010 Sep-Oct; 29 (5): 297-300
• Cyberknife stereotactic radiosurgery for treatment of atypical (WHO grade II) cranial meningiomas. Choi CY, Soltys SG, Gibbs IC, Harsh GR, Jackson PS, Lieberson RE, Chang SD, Adler JR. Neurosurgery. 2010; 67 (5): 1180-8
• Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, Brown JM. J Clin Invest. 2010; 120 (3): 694-705
• Passive antibody-mediated immunotherapy for the treatment of malignant gliomas. Mitra S, Li G, Harsh GR. Neurosurg Clin N Am. 2010; 21 (1): 67-76
• Lanreotide promotes apoptosis and is not radioprotective in GH3 cells. Ning S, Knox SJ, Harsh GR, Culler MD, Katznelson L. Endocr Relat Cancer. 2009; 16 (3): 1045-55
• Papillary tumor of the spinal cord: report of 2 cases. Mobley B, Kalani MY, Harsh GR, Edwards MS, Vogel H. Am J Surg Pathol. 2009; 33 (8): 1191-7
• Predictors of peritumoral edema after stereotactic radiosurgery of supratentorial meningiomas. Patil CG, Hoang S, Borchers DJ, Sakamoto G, Soltys SG, Gibbs IC, Harsh GR, Chang SD, Adler JR. Neurosurgery. 2008; 63 (3): 435-40; discussion 440-2
• Efficacy and safety of CyberKnife radiosurgery for acromegaly. Roberts BK, Ouyang DL, Lad SP, Chang SD, Harsh GR, Adler JR, Soltys SG, Gibbs IC, Remedios L, Katznelson L. Pituitary. 2007; 10 (1): 19-25
• National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002. Patil CG, Lad SP, Harsh GR, Laws ER, Boakye M. Neurosurg Focus. 2007; 23 (3): E7
• Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. Bredel M, Bredel C, Juric D, Duran GE, Yu RX, Harsh GR, Vogel H, Recht LD, Scheck AC, Sikic BI. J Clin Oncol. 2006; 24 (2): 274-87
• Amplification of whole tumor genomes and gene-by-gene mapping of genomic aberrations from limited sources of fresh-frozen and paraffin-embedded DNA. Bredel M, Bredel C, Juric D, Kim Y, Vogel H, Harsh GR, Recht LD, Pollack JR, Sikic BI. J Mol Diagn. 2005; 7 (2): 171-82
• Anterior skull base surgery. Kaplan MJ, Fischbein NJ, Harsh GR. Otolaryngol Clin North Am. 2005; 38 (1): 107-31, ix
• Characterization of the integrin alpha v beta3 in arteriovenous malformations and cavernous malformations. Lim M, Haddix T, Harsh GR, Vogel H, Steinberg GK, Guccione S. Cerebrovasc Dis. 2005; 20 (1): 23-7
• Concomitant ectatic posterior communicating artery and tentorial meningioma as a source of oculomotor palsy: case report. Babbitz JD, Harsh GR. Neurosurgery. 2005; 57 (6): E1316; discussion E1316
• Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI. Cancer Res. 2005; 65 (19): 8679-89
• High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI. Cancer Res. 2005; 65 (10): 4088-96
• Identification of phenotypic neural stem cells in a pediatric astroblastoma. Huhn SL, Yung Y, Cheshier S, Harsh G, Ailles L, Weissman I, Vogel H, Tse V. J Neurosurg. 2005; 103 (5 Suppl): 446-50
• alpha(v)beta(3) Integrin in central nervous system tumors. Lim M, Guccione S, Haddix T, Sims L, Cheshier S, Chu P, Vogel H, Harsh G. Hum Pathol. 2005; 36 (6): 665-9
• Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators. Tse V, Yung Y, Santarelli JG, Juan D, Hsiao M, Haas M, Harsh G, Silverberg G. Anticancer Res. 2004 Jan-Feb; 24 (1): 1-10
• Magnetic resonance image-guided proteomics of human glioblastoma multiforme. Hobbs SK, Shi G, Homer R, Harsh G, Atlas SW, Bednarski MD. J Magn Reson Imaging. 2003; 18 (5): 530-6
• Pituitary apoplexy after leuprolide injection for ovum donation. Engel G, Huston M, Oshima S, Beck C, Harsh G, Rosenthal MH, Camargo CA. J Adolesc Health. 2003; 32 (1): 89-93
• Quality assurance of magnetic resonance spectroscopic imaging-derived metabolic data. Hunjan S, Adalsteinsson E, Kim DH, Harsh GR, Boyer AL, Spielman D, Xing L. Int J Radiat Oncol Biol Phys. 2003; 57 (4): 1159-73
• Synchronous subarachnoid drop metastases from a pituitary adenoma with multiple recurrences. Case report. Lehman NL, Horoupian DS, Harsh GR. J Neurosurg. 2003; 98 (5): 1120-3
• The temporal-spatial expression of VEGF, angiopoietins-1 and 2, and Tie-2 during tumor angiogenesis and their functional correlation with tumor neovascular architecture. Tse V, Xu L, Yung YC, Santarelli JG, Juan D, Fabel K, Silverberg G, Harsh G. Neurol Res. 2003; 25 (7): 729-38
• Dural marginal zone lymphoma with massive amyloid deposition: rare low-grade primary central nervous system B-cell lymphoma. Case report. Lehman NL, Horoupian DS, Warnke RA, Sundram UN, Peterson K, Harsh GR. J Neurosurg. 2002; 96 (2): 368-72
• Proton beam stereotactic radiosurgery of vestibular schwannomas. Harsh GR, Thornton AF, Chapman PH, Bussiere MR, Rabinov JD, Loeffler JS. Int J Radiat Oncol Biol Phys. 2002; 54 (1): 35-44
• Daily low-dose carboplatin as a radiation sensitizer for newly diagnosed malignant glioma. Peterson K, Harsh G, Fisher PG, Adler J, Le Q. J Neurooncol. 2001; 53 (1): 27-32
• Pedicled rhinotomy for clival chordomas invaginating the brainstem. Harsh G, Ojemann R, Varvares M, Swearingen B, Cheney M, Joseph M. Neurosurg Focus. 2001; 10 (3): E8
• Cranial reconstruction for metastatic breast cancer. Sieveking NE, Turk AE, Beck CE, Harsh G. Plast Reconstr Surg. 2000; 105 (5): 1737-41
• Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. Harsh GR, Deisboeck TS, Louis DN, Hilton J, Colvin M, Silver JS, Qureshi NH, Kracher J, Finkelstein D, Chiocca EA, Hochberg FH. J Neurosurg. 2000; 92 (5): 804-11